Long-Term Organ Preservation in Rectal Cancer Is Possible Long-Term Organ Preservation in Rectal Cancer Is Possible
Long-term data from the OPRA trial show organ preservation at 5 years in about half of patients with stage II/III rectal adenocarcinoma who received total neoadjuvant therapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 28, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Surgery Is Falling Out of Favor in Rectal Cancer Surgery Is Falling Out of Favor in Rectal Cancer
With organ preservation on the rise, investigators say practice guidelines need to catch up.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 20, 2023 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news
Global Surge In Colo-Rectal Cancer Linked To Junk Food
Scientists have found a link between a recent global surge in colorectal cancer and processed or “junk” food. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 31, 2023 Category: Pharmaceuticals Authors: Daphne Ewing-Chow, Senior Contributor Tags: Food & Drink /food-drink Business /business Innovation /innovation Healthcare /healthcare standard Source Type: news
Predicting Recurrence in Rectal Cancer Watchful Waiting Predicting Recurrence in Rectal Cancer Watchful Waiting
Investigators reported that the Immunoscore biopsy, which quantifies immune cell tumor infiltration, is a strong predictor of recurrence during watchful waiting for rectal cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 19, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
NCI Task Force Issues Rectal Cancer Trial Design Recs NCI Task Force Issues Rectal Cancer Trial Design Recs
The consensus recommendations address key areas in rectal cancer trial design, including the need to incorporate endpoints important to patients and establish the optimal use of neoadjuvant therapy.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - August 16, 2023 Category: Gastroenterology Tags: Hematology-Oncology Source Type: news
Does Timing of Surgery Affect Rectal Cancer Outcomes? Does Timing of Surgery Affect Rectal Cancer Outcomes?
Waiting more than 12 weeks for surgery following neoadjuvant therapy was associated with improved tumor regression grade and reduced risk of systemic recurrence but not overall survival.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 14, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Episode 3: Treating Rectal Cancer: PROSPECT, PRODIGE, or OPRA? Episode 3: Treating Rectal Cancer: PROSPECT, PRODIGE, or OPRA?
Join Drs Benjamin Schlechter and Harvey Mamon as they discuss treatment options for patients with stage II and III rectal cancer based on new data from the most recent clinical trial results.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 6, 2023 Category: Consumer Health News Tags: Radiology InDiscussion Source Type: news
Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer? Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer?
Neoadjuvant chemoradiotherapy can be omitted in low-risk rectal cancer patients without compromising outcomes, but intensified in high-risk patients, new findings suggest.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 27, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
MRI Identifies Rectal Cancer Patients Who Can Skip CRT MRI Identifies Rectal Cancer Patients Who Can Skip CRT
Patients with stage I-III rectal cancer typically undergo chemoradiation before surgery, but MRI can identify those who could skip this step and go straight to upfront surgery.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 26, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Locally Recurrent Rectal Cancer QoL Is Valid Patient-Reported Outcome Measure
FRIDAY, June 9, 2023 -- A new locally recurrent rectal cancer (LRRC) quality of life (QoL) measure is a valid patient-reported outcome measure (PROM), according to a study published in the May issue of eClinicalMedicine.
Deena P. Harji, M.B.B.S.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 9, 2023 Category: Pharmaceuticals Source Type: news
ASCO: FOLFOX Noninferior to Chemoradiotherapy for Overall Survival in Rectal Cancer
FRIDAY, June 9, 2023 -- Neoadjuvant chemotherapy with fluorouracil, leucovorin, and oxaliplatin (FOLFOX) is noninferior to preoperative chemoradiotherapy with respect to overall survival for patients with locally advanced rectal cancer who are... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 9, 2023 Category: Pharmaceuticals Source Type: news
Some Cancer Patients Might Safely Skip Radiation Therapy
New clinical trials shows radiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment. (Source: WebMD Health)
Source: WebMD Health - June 6, 2023 Category: Consumer Health News Source Type: news
Some Cancer Patients Might Safely Skip Radiation Therapy
New clinical trials show radiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment. (Source: WebMD Health)
Source: WebMD Health - June 6, 2023 Category: Consumer Health News Source Type: news
Can Some Cancer Patients Safely Skip Radiation Therapy? New Studies Say Yes
TUESDAY, June 6, 2023 -- Radiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment, a pair of new clinical trials shows.
One trial found that rectal cancer patients... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 6, 2023 Category: General Medicine Source Type: news
Omitting RT Safe in Many Locally Advanced Rectal Cancers
(MedPage Today) -- CHICAGO -- Standard pelvic chemoradiotherapy prior to surgery can be safely omitted in select patients with locally advanced rectal cancer whose tumors respond to neoadjuvant chemotherapy, findings from a large cooperative... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 5, 2023 Category: Gastroenterology Source Type: news
